Big pharma, big data: Why drugmakers want your health records


  • TECH
  • Sunday, 04 Mar 2018

FILE PHOTO: A surgery nurse is seen beside the heart beat monitor in the operating theatre of the Unfallkrankenhaus Berlin (UKB) hospital in Berlin, Germany February 29, 2008. REUTERS/Fabrizio Bensch /File Photo

LONDON: Drugmakers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start to unlock a trove of information about how medicines perform in the real world. 

Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs – something Roche aims to leverage, for example, with last month's US$2bil (RM7.81bil) purchase of Flatiron Health. 

Start your ads-free experience now!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Tech News

Bitcoin miners pivot to South-East Asia after�China crackdown
China elder care sector plugs smart gadgets to fill workforce gaps
French tech firms warn immigration curbs could threaten AI ambitions
Chinese football fans are pouring money into a food stall run by Singapore’s goalkeeper. Here’s why
How Amazon blew Alexa’s shot to dominate AI, according to more than a dozen employees who worked on it
Mark Zuckerberg’s ‘year of efficiency’ at Meta has spread to the company’s upper ranks and incompetent VPs are next to be culled
ByteDance fails to block trademark application for now-defunct short video app
After several near-misses on airport runways, a tech company revives work on a hazard-warning system
Fake news still has a home on Facebook
Explainer-What is Weverse, 'super app' joined by Ariana Grande?

Others Also Read